Ordered, immediately called back and the same day delivered the order.Very pleased with the work. Thank you for prompt and accurate work amoxil online great prices, delivered on the day of the order. Pleasant managers consult by phone.
Academic Year 2002-03
− Division I
Sign and return to your director of athletics
In sports in which the Association conducts year-round drug-testing, at the time your intercollegiate squad first reports for practice or before the Monday of your institution's fourth week of classes (whichever date occurs first).
In sports in which the Association does not conduct year-round drug testing, before the institution's first scheduled intercolle-giate competition.
NCAA Constitution 22.214.171.124 and NCAA Bylaws 14.1.4 and 30.5
Name of your institution: _________________________________________________________
You must sign this form to participate (i.e., practice or compete) in intercollegiate athletics. Per
NCAA Bylaw 30.5-(b), the director of athletics or the director of athletics’ designee shall dis-
seminate a copy of the list of banned drug classes to each student-athlete (Attachment A of
NCAA Constitution 126.96.36.199 and NCAA Bylaws 14.1.4 and 30.5 require that you sign this form.
If you have any questions, you should discuss them with your director of athletics.
By signing this form, you affirm that you are aware of the NCAA drug-testing program, which
A student-athlete who is found to have used a substance on the list of banned drugs, as set forth
in Bylaw 188.8.131.52, shall be declared ineligible
for further participation in regular season and
postseason competition in all sports in accordance with the provisions in Bylaw 184.108.40.206.1. The
certifying institution may appeal to the NCAA Student-Athlete Reinstatement Committee for
restoration of the student-athlete's eligibility if the institution concludes that circumstances war-
rant restoration. (Bylaw 220.127.116.11)
A student-athlete who tests positive (in accordance with the testing methods authorized by the
NCAA Executive Committee) shall be ineligible
to participate in regular-season and postseason
competition for one calendar year (i.e., 365 days) after the positive drug test and shall be charged
Drug-Testing Consent − Division I
Page No. 2
with the loss of a minimum of one season of competition in all sports. The student-athlete shall
for all regular-season and postseason competition for one calendar year after
the student-athlete's positive drug test, and until the student-athlete retests negative (in accor-
dance with the testing methods authorized by the Executive Committee) and the student-athlete's
eligibility is restored by the Student-Athlete Reinstatement Committee. If a student-athlete
transfers to another NCAA institution while ineligible due to a positive NCAA drug test, the in-
stitution from which the student-athlete transfers must notify the transfer institution regarding the
positive drug test result.
If the student-athlete tests positive a second time for the use of any drug, other than a "street
drug" as defined in Bylaw 18.104.22.168, he or she shall lose all remaining regular-season and postsea-
son eligibility in all sports. In addition, the penalty for missing a scheduled drug test is the same
as the penalty for testing positive for the use of a banned drug.
If the student-athlete tests positive for the use of a "street drug" after being restored to eligibility,
he or she shall be charged with the loss of a minimum of one additional season of competition in
all sports and also shall remain ineligible
for regular-season and postseason competition at least
through the next calendar year. If the student-athlete transfers to another NCAA institution
while ineligible, the institution from which the student-athlete transferred must notify the institu-
tion that the student-athlete is ineligible due to a positive drug test result. If the student-athlete
immediately transfers to a non-NCAA institution while ineligible and competes in collegiate
competition within the 365-day period at a non-NCAA institution, the student-athlete will be in-
eligible for all NCAA regular-season and postseason competition until the student-athlete does
not compete in collegiate competition for a 365-day period. Additionally, the student-athlete
must retest negative (in accordance with the testing methods authorized by the Executive Com-
mittee) and request that eligibility be restored by the Academic/Eligibility/Compliance Cabinet.
The Executive Committee shall adopt a list of banned drugs and shall authorize methods for drug
testing of student-athletes on a year-round basis. This list of banned drugs and the procedure for
informing member institutions about authorized methods for drug testing are set forth in Bylaws
22.214.171.124 and 126.96.36.199 respectively. The list is subject to change and the institution and student-
athlete shall be held accountable for all banned drug classes on the current list (see Attachment
A of this form)
. The list is locateday be ob-
tained from the NCAA health and safety staff in Education Outreach. (Bylaw 188.8.131.52.2)
You agree to allow the NCAA to test you in relation to any participation by you in any NCAA
championship or in any postseason football game certified by the NCAA for the banned drugs
listed in Bylaw 184.108.40.206. Additionally, if you participate in Division I football or track and field,
you also agree to be tested on a year-round basis for anabolic agents, diuretics, ephedrine and
Drug-Testing Consent − Division I Form 02-3d Page No. 3 ________ You were provided an opportunity to review the procedures for NCAA drug testing that are de-scribed in the NCAA Drug-Testing Program brochure. You understand that this consent and the results of your drug tests, if any, only will be disclosed in accordance with the provisions of the Buckley Amendment consent. You agree to disclose your drug-testing results only for purposes related to your eligibility for participation in regular-season and postseason competition. You affirm that you understand that if you sign this statement falsely or erroneously, you violate NCAA legislation on ethical conduct, and you will further jeopardize your eligibility. _______________________ _________________________________________________ Date
_______________________ _________________________________________________ Date
Signature of Parent (if student-athlete is a minor)
What to do with this form:
Sign and return it to your director of athletics at the time your in-
tercollegiate squad first reports for practice or before the Monday of your institution's fourth
week of classes, whichever date occurs first. This form is to be kept in the director of athletics
office for six years.
The National Collegiate Athletic Association July 3, 2002
Drug-Testing Consent − Division I Form 02-3d Page No. 4 _________
NCAA Banned Drugs
*Per NCAA Bylaw 30.5-(b), the director of athletics or the director of athletics’ designee shall
disseminate a copy of the list of banned drug classes to each student-athlete.
Please note that the list of banned drugs is subject to change by the NCAA Executive Committee, and the institution
and student-athlete shall be held accountable for all banned drug classes on the current list. Updates to the list of
banned drugs can be found via the NCAA web site
The term "related compounds" comprises substances that are included in the class by their pharmacological action
and/or chemical structure.
No substance belonging to the prohibited class may be used, regardless of whether it is specifically listed as an ex-
The following is the list of banned-drug classes, pursuant to NCAA Division I Bylaw 220.127.116.11.
methylene-dioxymethamphetamine (MDMA, prolintane
(b) Anabolic Agents:
Drug-Testing Consent − Division I
Page No. 5
________ (c) Substances Banned for Specific Sports:
(e) Street Drugs:
(f) Peptide Hormones and Analogues
chorionic gonadotrophin (HCG - human chorionic gonadotrophin)
growth hormone (HGH, somatotrophin) *All the respective releasing factors of the
above-mentioned substances also are banned
(g) Definitions of positive depends on the following:
1 for caffeine-if the concentration in urine exceeds 15 micrograms/ml.
2 for testosterone-if the administration of testosterone or the use of any other manipulation has the result of increas-ing the ratio of the total concentration of testosterone to that of epitestosterone in the urine to greater than 6:1, unless there is evidence that this ratio is due to a physiological or pathological condition.
3 for marijuana and THC-if the concentration in the urine of THC metabolite exceeds 15 nanograms/ml.
* The term "related compounds" comprises substances that are included in the class by their pharmacological action
and/or chemical structure. No substance belonging to the prohibited class may be used, regardless of whether it is
specifically listed as an example.
Nutritional supplements are not strictly regulated and may contain substances banned by the NCAA. For questions
regarding nutritional supplements, please visit th
The National Collegiate Athletic Association July 3, 2002
Contending Issues of Intellectual Property Rights Protection and Indigenous Knowledge of Pharmacology in Africa South of the Sahara www.chikaforafrica.com; www.beforewesetsail.com; email@example.com Executive Director, African Centre for Education Research and Transformation Washington D.C.; Director, African Institute for Research in Abstract Indigenous knowledge is beginning
Dénomination du médicament HUMEX ALLERGIE LORATADINE 10 mg, comprimé Loratadine Encadré Veuillez lire attentivement cette notice avant de prendre ce médicament. Elle contient des informations importantes pour votre traitement. · Ce médicament peut être utilisé en automédication c'est-à-dire utilisé sans consultation ni prescription d'unmédecin. · Si les symptômes per